Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant

被引：94
|
作者：
Uriu, Keiya [1 ,4 ]
Ito, Jumpei [1 ]
Zahradnik, Jiri [5 ,6 ]
Fujita, Shigeru [1 ,4 ]
Kosugi, Yusuke [1 ,4 ]
Schreiber, Gideon [5 ]
Sato, Kei [1 ,2 ,3 ,4 ,7 ,8 ,9 ]
机构：
[1] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Syst Virol, Tokyo, Japan
[2] Univ Tokyo, Inst Med Sci, Int Vaccine Design Ctr, Tokyo, Japan
[3] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Tokyo, Japan
[4] Univ Tokyo, Grad Sch Med, Tokyo, Japan
[5] Weizmann Inst Sci, Dept Biomol Sci, Rehovot, Israel
[6] Charles Univ Prague, Med Fac Biocev 1, Prague, Czech Republic
[7] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Japan
[8] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Collaborat Unit Infect, Kumamoto, Japan
[9] Japan Sci & Technol Agcy, CREST, Kawaguchi, Japan
来源：
LANCET INFECTIOUS DISEASES | 2023年 / 23卷 / 03期
关键词：
D O I：
10.1016/S1473-3099(23)00051-8
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：280 / 281
页数：2
相关论文
共 50 条
  • [1] Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
    Tomokazu Tamura
    Takashi Irie
    Sayaka Deguchi
    Hisano Yajima
    Masumi Tsuda
    Hesham Nasser
    Keita Mizuma
    Arnon Plianchaisuk
    Saori Suzuki
    Keiya Uriu
    Mst Monira Begum
    Ryo Shimizu
    Michael Jonathan
    Rigel Suzuki
    Takashi Kondo
    Hayato Ito
    Akifumi Kamiyama
    Kumiko Yoshimatsu
    Maya Shofa
    Rina Hashimoto
    Yuki Anraku
    Kanako Terakado Kimura
    Shunsuke Kita
    Jiei Sasaki
    Kaori Sasaki-Tabata
    Katsumi Maenaka
    Naganori Nao
    Lei Wang
    Yoshitaka Oda
    Terumasa Ikeda
    Akatsuki Saito
    Keita Matsuno
    Jumpei Ito
    Shinya Tanaka
    Kei Sato
    Takao Hashiguchi
    Kazuo Takayama
    Takasuke Fukuhara
    Nature Communications, 15
  • [2] SARS-CoV-2 variant omicron XBB.1.5: challenges and prospects
    Channabasappa, Nikhil K.
    Niranjan, Ankush K.
    Emran, Talha B.
    INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (04) : 1054 - 1055
  • [3] Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
    Tamura, Tomokazu
    Irie, Takashi
    Deguchi, Sayaka
    Yajima, Hisano
    Tsuda, Masumi
    Nasser, Hesham
    Mizuma, Keita
    Plianchaisuk, Arnon
    Suzuki, Saori
    Uriu, Keiya
    Begum, Mst Monira
    Shimizu, Ryo
    Jonathan, Michael
    Suzuki, Rigel
    Kondo, Takashi
    Ito, Hayato
    Kamiyama, Akifumi
    Yoshimatsu, Kumiko
    Shofa, Maya
    Hashimoto, Rina
    Anraku, Yuki
    Kimura, Kanako Terakado
    Kita, Shunsuke
    Sasaki, Jiei
    Sasaki-Tabata, Kaori
    Maenaka, Katsumi
    Nao, Naganori
    Wang, Lei
    Oda, Yoshitaka
    Sawa, Hirofumi
    Kawabata, Ryoko
    Watanabe, Yukio
    Sakamoto, Ayaka
    Yasuhara, Naoko
    Suzuki, Tateki
    Nakajima, Yukari
    Ferdous, Zannatul
    Shishido, Kenji
    Mugita, Yuka
    Takahashi, Otowa
    Ichihara, Kimiko
    Kaku, Yu
    Misawa, Naoko
    Guo, Ziyi
    Hinay, Alfredo, Jr.
    Kosugi, Yusuke
    Fujita, Shigeru
    Tolentino, Jarel M.
    Chen, Luo
    Pan, Lin
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [4] XBB.1.5: A new threatening SARS-CoV-2 Omicron subvariant
    Islam, Md. Aminul
    Kaifa, Fatema Hasan
    Chandran, Deepak
    Bhattacharya, Manojit
    Chakraborty, Chiranjib
    Bhattacharya, Prosun
    Dhama, Kuldeep
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [5] XBB.1.5 Kraken cracked: Gibbs energies of binding and biosynthesis of the XBB.1.5 variant of SARS-CoV-2
    Popovic, Marko E.
    MICROBIOLOGICAL RESEARCH, 2023, 270
  • [6] Emergence and dissemination of SARS-CoV-2 XBB.1.5 in New York
    Gambaro, Fabiana
    Duerr, Ralf
    Dimartino, Dacia
    Marier, Christian
    Iturrate, Eduardo
    Mulligan, Mark J.
    Heguy, Adriana
    Dellicour, Simon
    VIRUS EVOLUTION, 2024, 10 (01)
  • [7] Editorial: The XBB.1.5 (Kraken') Subvariant of Omicron SARS-CoV-2 and its Rapid Global Spread
    Parums, Dinah, V
    MEDICAL SCIENCE MONITOR, 2023, 29
  • [8] An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants
    Liu, Zongming
    Li, Jiaxuan
    Pei, Shanshan
    Lu, Ying
    Li, Chaonan
    Zhu, Jiajie
    Chen, Ruyi
    Wang, Di
    Sun, Jingbo
    Chen, Keda
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [9] The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
    Kimura, Izumi
    Kosugi, Yusuke
    Wu, Jiaqi
    Zahradnik, Jiri
    Yamasoba, Daichi
    Butlertanaka, Erika P.
    Tanaka, Yuri L.
    Uriu, Keiya
    Liu, Yafei
    Morizako, Nanami
    Shirakawa, Kotaro
    Kazuma, Yasuhiro
    Nomura, Ryosuke
    Horisawa, Yoshihito
    Tokunaga, Kenzo
    Ueno, Takamasa
    Takaori-Kondo, Akifumi
    Schreiber, Gideon
    Arase, Hisashi
    Motozono, Chihiro
    Saito, Akatsuki
    Nakagawa, So
    Sato, Kei
    CELL REPORTS, 2022, 38 (02):
  • [10] The rapid rise of SARS-CoV-2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
    Ao, Danyi
    He, Xuemei
    Hong, Weiqi
    Wei, Xiawei
    MEDCOMM, 2023, 4 (02):
12345